|
Senate Bills - 108th Congress
Session I | Session II
S. 15Project BioShield Act of 2003 and the Biodefense Improvement and Treatment for America Act
On March 19, 2003, the Senate Committee on Health, Education, Labor and Pensions
(Senator Judd Gregg [R-NH], Chairman) reported out, by a vote of 21 to 0, S. 15, the
Project BioShield Act of 2003, with an amendment in the nature of a substitute by
Senator Gregg. The Project BioShield Act of 2003 is Title 11 of the original bill
introduced by Senator Gregg on March 11 as the Biodefense Improvement and Treatment for
America Act. The Project BioShield Act of 2003, would provide the Secretary of HHS with
authorities for expedited procurement and peer review related to biomedical
countermeasures research, and for securing the personal services of experts or
consultants with relevant expertise. NIAID would be designated the lead institute for
biological countermeasures research at NIH.
The original S. 15, the Biodefense Improvement and Treatment for America Act, would
amend the Public Health Service Act to provide for the payment of compensation for
certain individuals with injuries resulting from the administration of smallpox
countermeasures; to provide protections and countermeasures against chemical,
radiological, or nuclear agents that may be used in a terrorist attack against the
United States; and to improve immunization rates by increasing the distribution of
vaccines and improving and clarifying the vaccine injury compensation program.
COMMITTEE/SUBCOMMITTEE ACTION
May 19, 2004 – The Senate passed S. 15 by a vote of 99-0.
July 14, 2004 – The House passed S. 15 by a vote of 414-2.
PRESIDENTIAL ACTION
July 21, 2004 – The President signed S. 15 into law as P.L. 108-276.
Legislative Update (August 2004):
Project BioShield Act of 2004
Legislative Update (August 2003):
Biological, Chemical, Radiological, and Nuclear Defense
|
|